0001144204-16-101709.txt : 20160513 0001144204-16-101709.hdr.sgml : 20160513 20160513150115 ACCESSION NUMBER: 0001144204-16-101709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160511 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alliqua BioMedical, Inc. CENTRAL INDEX KEY: 0001054274 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582349413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1010 STONY HILL ROAD STREET 2: SUITE 200 CITY: YARDLEY STATE: PA ZIP: 19067 BUSINESS PHONE: 215-702-8550 MAIL ADDRESS: STREET 1: 1010 STONY HILL ROAD STREET 2: SUITE 200 CITY: YARDLEY STATE: PA ZIP: 19067 FORMER COMPANY: FORMER CONFORMED NAME: Alliqua, Inc. DATE OF NAME CHANGE: 20101222 FORMER COMPANY: FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC DATE OF NAME CHANGE: 20030529 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP DATE OF NAME CHANGE: 20030219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARTON BRADFORD CENTRAL INDEX KEY: 0001618553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36278 FILM NUMBER: 161647840 MAIL ADDRESS: STREET 1: C/O ALLIQUA BIOMEDICAL, INC. STREET 2: 2150 CABOT BLVD. WEST CITY: LANGHORNE STATE: PA ZIP: 19047 4 1 v439857_4.xml OWNERSHIP DOCUMENT X0306 4 2016-05-11 0 0001054274 Alliqua BioMedical, Inc. ALQA 0001618553 BARTON BRADFORD C/O ALLIQUA BIOMEDICAL, INC. 1010 STONY HILL ROAD YARDLEY PA 19067 0 1 0 0 Chief Operating Officer Common Stock 2016-05-11 4 A 0 100000 0 A 245643 D Represents a restricted stock award that is subject to forfeiture until vested. The award vests in three equal installments based on the Issuer's satisfaction of certain performance criteria prior to May 11, 2021, with one-third (1/3) of the awarded shares vesting on each date, if any, that the Issuer files a report with the SEC reporting audited annual gross revenues that equal or exceed each of $25 million, $30 million and $36 million, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the reporting person, effective as of May 11, 2016. /s/ Bradford Barton 2016-05-13